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Repetitive protein-based polymers are important for many applications in biotechnology and 19 
biomaterials development. Here we describe the sequential additive ligation of highly repetitive 20 
DNA sequences, their assembly into genes encoding protein-polymers with precisely tunable 21 
lengths and compositions, and their end-specific post-translational modification with organic 22 
dyes and fluorescent protein domains. Our new Golden Gate-based cloning approach relies on 23 
incorporation of only type IIS BsaI restriction enzyme recognition sites using PCR, which 24 
allowed us to install ybbR-peptide tags, Sortase c-tags, and cysteine residues onto either end of 25 
the repetitive gene polymers without leaving any cloning scars. The assembled genes were 26 
expressed in Escherichia coli and purified using inverse transition cycling (ITC). 27 
Characterization by cloud point spectrophotometry, and denaturing polyacrylamide gel 28 
electrophoresis with fluorescence detection confirmed successful phosphopantetheinyl 29 
transferase (Sfp)-mediated post-translational N-terminal labeling of the protein-polymers with a 30 
Coenzyme A-647 dye (CoA-647), and simultaneous Sortase-mediated C-terminal labeling with a 31 
GFP domain containing an N-terminal GG-motif in a one pot reaction. In a further 32 
demonstration, we installed an N-terminal cysteine residue into a 60 pentapeptide ELP that was 33 
subsequently conjugated to a single chain poly(ethylene glycol)-maleimide (PEG-maleimide) 34 
synthetic polymer, noticibly shifting the ELP cloud point. The ability to straightforwardly 35 
assemble repetitive DNA sequences encoding ELPs of precisely tunable length, and to post-36 
translationally modify them specifically at the N- and C- termini provides a versatile platform for 37 
the design and production of multi-functional smart protein-polymeric materials.  38 
 39 
INTRODUCTION 40 
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Repetitive polymers of controlled length and tunable phase-transition behavior are urgently 41 
needed for a variety of applications in the nano/biosciences, including drug delivery
1,2
, and 42 
medical diagnostics
3
. Such stimuli-responsive polymeric materials are of high interest for 43 
fundamental investigations into biomolecules under the influence of mechanical, thermal, and 44 
chemical denaturants using biophysical methods such as single-molecule AFM force 45 
spectroscopy
4,5
 and microscale thermophoresis
6
. Elastin like polypeptides (ELPs) are artificial 46 
proteins derived from naturally occurring elastomeric proteins
7,8
. Recombinant ELPs consist of 47 
repeats of the amino acid sequence Val-Pro-Gly-Xaa-Gly, where Xaa represents any amino acid 48 
except proline. ELPs exhibit a reversible lower critical solution temperature (LCST), and 49 
undergo a phase transition that can be triggered by temperature
9
. Other environmental stimuli 50 
like pH or ionic strength can also be used to collapse ELPs under isothermal conditions. The 51 
guest residue (Xaa) can be used to influence the pH/thermal phase transition properties of the 52 
resulting protein-polymers. Insertion of acidic residues such as glutamate or aspartate in the 53 
guest residue position results in pH-responsive behavior. The transition temperature is strongly 54 
dependent on the concentration and molecular weight, with longer ELP sequences collapsing at 55 
lower temperatures. One can also tune the cloud point by changing several environmental 56 
parameters at once (e.g., temperature, pH, salt), thereby shifting the transition to lower or higher 57 
temperatures as desired
10
. 58 
 59 
These unique properties of ELPs make them attractive for a variety of applications and scientific 60 
investigations
11
. Chromatography free protein purification, for example, can be performed by 61 
producing a target protein as an ELP fusion, and precipitating it from cellular extracts, avoiding 62 
the need for affinity tags. This method allows for purification of recombinant proteins under mild 63 
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conditions. Moreover, it is reported that in combination with maltose binding proteins, ELPs can 64 
improve the solubility of fusion domains and thereby improve expression yields
12–14
.  65 
 66 
In the field of biomaterials science, ELPs represent a viable option as a scaffold material for 67 
tissue engineering, or as carriers for drug molecules. Applications for in vivo systems demand 68 
high predictability and controllability of the biophysical behavior of the molecules. Since ELPs 69 
consist only of amino acids, they are competitive in terms of biocompatibility and biodegradation 70 
in vivo as compared to their synthetic organic polymer counterparts
15,16
. ELPs possess the added 71 
advantage of complete monodispersity. More fundamentally, the phase transition characteristics 72 
of ELPs have served as an ideal model system for theoretical calculations and modeling 73 
studies
17–21
. Additionally, conjugates between ELPs and synthetic polymers (e.g., PEG) are of 74 
high interest, and would benefit from site-specific conjugation approaches
22,23
.  75 
 76 
In order to fully leverage the versatility of repetitive protein-polymers such as ELPs, modular 77 
and straightforward approaches to cloning and site-specific post-translational modification are 78 
highly desirable. Standard solid-phase gene synthesis methods are so far not able to produce the 79 
long (>600 bp) strands of repetitive DNA required for encoding thermally responsive elastin-like 80 
polypeptides (ELPs) with lengths > 200 amino acids. Typically rationally designed ELPs are 81 
constructed using recursive directional ligation (RDL), which requires plasmid amplification, 82 
and restriction digestion, and imposes certain restrictions (i.e., the absence of restriction sites)
24
. 83 
Larger ELP genes can also be obtained with the OERCA (overlap extension rolling circle 84 
amplification) method, which generates a distribution of unspecified lengths of repetitive DNA 85 
sequences
25
.  86 
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 87 
Compared to the RDL method our Golden Gate approach presented here avoids cloning scars 88 
due to the use of type IIS restriction enzymes, and is able to cut scarlessly within the coding 89 
region
24,26
. The PRe-RDL (RDL by plasmid reconstruction) method relies on several type IIS 90 
restriction enzymes and requires certain modifications of the backbone beforehand
27
.  91 
 92 
Our method is applicable to a broad spectrum of plasmids, since the only limitation is one type 93 
IIS restriction enzyme with a recognition site not present in the backbone. Along with this 94 
advantage, it is likewise ideal for adding ELPs to an existing gene-containing plasmid to create 95 
fusion proteins with different length ELPs. The combinational possibilities also do not rely on a 96 
plasmid library, but can be designed using a bottom up block assembly approach. Our approach 97 
can also be used in a complimentary way with the existing RDL and OERCA methods, for 98 
example, by easily generating fast and reliable plasmid libraries which can then be further 99 
extended by combining with RDL or OERCA methods.  100 
 101 
We present a sequence independent approach based on the Golden Gate technology employing 102 
polymerase chain reaction (PCR) amplification of short ELP repeats and ligation into a plasmid 103 
backbone to produce repetitive ELP genes with specific peptide tag end groups for covalent post-104 
translational modification. A single type IIS restriction enzyme is used to create unique ends and 105 
guarantee the order of DNA block assembly. Using this method, repetitive DNA sequences up to 106 
hundreds of nm in length (i.e., 120 pentapeptide repeats of ELPs) can be rationally designed and 107 
created. 5’ and 3’ tags for post-translational modifications were readily incorporated during the 108 
cloning workflow, providing many further possibilities for downstream conjugation and labeling. 109 
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Due to the modularity of the system, we were also able to readily install peptide tags (i.e., ybbR
28
 110 
and Sortase sequences) to the ELP, enabling enzyme-catalyzed ligation of the peptides to 111 
fluorescent proteins and organic dyes (as shown below). Our approach builds on the prior 112 
method shown by Huber et al. which demonstrated fusion of different kinds of repetitive DNA to 113 
create chimeras of ELPs, silk peptides and similar proteins
29
. Our methodology is also 114 
compatible with their approach with the advantage of using only one type IIS restriction enzyme. 115 
 116 
Alternatively, it is possible to modify the carrier plasmid in the first amplification round and add 117 
ELP flanking tags or protein domains easily. Since the reaction starts new every three fragments, 118 
one can easily define block patterns that build up an overall sequence. For example, pH 119 
responsive blocks can be interspersed with pH-insensitive blocks. In regards to user-friendliness, 120 
the presented method is advantageous because it relies on the same ELP gene inserts, which can 121 
be reused. Once successful amplification and purification of the sequences is achieved, the PCR 122 
amplicons can be stored and used again as needed. This way it is possible to create a whole 123 
library of gene sequences and, if desired shuffle these each ligation cycle. Post-translational 124 
fusion of ELPs using Sortase ligation circumvents the known issue of low protein yields for N-125 
terminally located ELP domains in fusion proteins
30,31
. Instead of optimizing expression 126 
conditions for proteins of low yield, a protein of interest can be produced in its native state and 127 
fused afterwards post-translationally with the ELP domain. To the best of our knowledge, this 128 
represents the first report using a Sortase-based recognition sequence to fuse ELP proteins to 129 
other proteins
13,32
.   130 
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MATERIALS AND METHODS 131 
All used reagents were of analytical purity grade and were purchased from Sigma-Aldrich (St. 132 
Louis, MO, USA) or Carl Roth GmbH (Karlsruhe, Germany). 133 
 134 
Monomer Gene Synthesis. A synthetic gene encoding 150 nucleotides (10 pentapeptide repeats) 135 
for the (VPGVG)5-(VPGAG)2-(VPGGG)3 peptide (Centic Biotech, Heidelberg, Germany) served 136 
as starting material (see Supporting Information, DNA Sequence 1 and Protein Sequence 1).  137 
 138 
Cloning. Golden Gate cloning was employed to create the different rationally designed ELP 139 
constructs
26
. PCR (Backbone: 98°C 2 min, (98°C 7 s, 72°C 2 min 30 s) x30, 72°C 5 min; Insert: 140 
98°C 2 min, 98°C 7 s, 60°C 7s, 72°C 5 s) x30, 72°C 5 min) was performed with a Phusion high 141 
fidelity polymerase master mix. A typical 20 µl PCR mix contained 10 µl Phusion high fidelity 142 
polymerase master mix (Thermo Fisher Scientific Inc., Waltham, MA, USA), 0.5 µl per forward 143 
and reverse primer (10 µM), 1.5 µl DMSO, 1 ng of template and water. All primers (biomers.net, 144 
Ulm, Germany) used in this study are listed in Tab. 1.  145 
Table 1. Overview of employed primers 146 
Primer Sequence 5’ – 3’ 
(1a) FW ELP I ybbR 
TATATAGGTCTCCTGGCTGTGCCGGGAGAAGGAGTCCCTGG
TGTCGGTGTCCCAGGCG 
(1b) REV ELP I 
GGTCTCCTCCTTCACCCGGAACGCCACCCCCCGGAACACC
GCCGC 
(2a) FW ELP II 
TATATAGGTCTCAAGGAGTACCAGGCGAAGGCGTGCCGG
GTGTC 
(2b) REV ELP II 
ATATATGGTCTCACCCTCACCCGGAACGCCACCCCCCGGA
ACACCGCCGC 
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In the first round of PCR (see backbone PCR above, 55°C 7s annealing), the backbone of a 147 
modified pET28a vector (Merck KGaA, Darmstadt, Germany) was linearized. The PCR product 148 
contained at the 5’ end the sequence for a ybbR-tag (DSLEFIASKLA) and at the 3’ end a C-149 
terminal Sortase recognition sequence (LPETGG)
33,34
. Sequences of all PCR fragments 150 
(backbone, ELP I, II, III, IV) and a description for primer design (see Supporting Information, 151 
(3a) FW ELP III 
TATATAGGTCTCGAGGGTGTACCAGGCGAAGGGGTGCCGG
GTGTC 
(3b) REV ELP III 
LPETGG 
ATATATGGTCTCCGGCAGACCTTCACCCGGAACGCCACCCC
CCGGAACACCGCCGC 
(4) REV ELP III 
ATATATGGTCTCCACCTTCACCCGGAACGCCACCCCCCGG
AACACCGCCGC 
(5) FW backbone 
LPETGG 
ATATATGGTCTCCTGCCGGAAACCGGCGGCTAACTCGAGTA
AGATCCGGCTGC 
(6) REV backbone 
ybbR 
ATATATGGTCTCAGCCAGTTTAGAAGCGATGAATTCCAG 
(7) FW backbone 
ybbR 
GACTCTCTGGAATTCATCGCTTCTAAACTGGCTGGTCTCC
AGGTGTGCCGGGA 
(8) FW ELP II ybbR 
TATATAGGTCTCCTGGCGGTACCAGGCGAAGGGGTGCCGG
GTGTC 
(9) FW ELP III 
ybbR 
(10) FW ELP N Cys 
(11) REV backbone 
TATATAGGTCTCCTGGCGGTACCAGGCGAAGGCGTGCCGG
GTGTC 
GACTCTCTGGAATTCATCGCTTCTAAACTGGCTGGTCTCC
TGCGTGCCGGGAGAAGGAG 
CCCGGCACAGCCAGTTTAGAAGCGATGAATTCCAGAGAG
TCGGTCTCACATATGTATATC 
Primers 1 – 7 are employed for the cloning of the ELPs with 3 fragments growth every cycle. 
1-4 are the primers necessary for insert amplification, 5-7 for the amplification of the 
backbone. Primers 8 and 9 are only important for ELP cloning procedures with the addition of 
one or two fragments. Primers 10 and 11 were used to change the 5’ flanking site of the ELP 
gene from the gene for the ybbR-tag to a cysteine. DNA Sequence is styled in different ways: 
bold (annealing region), underlined (BsaI recognition site), highlighted in grey (BsaI 
restriction site) 
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Primer 12) based on an original pET28a vector are attached in the supporting information (Fig. 152 
S1 – S9, DNA Sequence 1-6 and Fig. S14-S18). 153 
 154 
The superfolder GFP (sfGFP) plasmid was created with Gibson Assembly
35
. The gene (Addgene 155 
ID: 58708)
36
 was amplified with overlaps to match a linearized vector containing sequences 156 
encoding N-terminal HIS6-tag, a TEV protease cleavage site and two glycines (compare the PCR 157 
program above; 55°C annealing and an extension time of 1 min. 30 s; see Supporting 158 
Information, DNA Sequence 8 and Protein Sequence 4). 159 
 160 
All PCR products were digested (37°C, 1 - 12 h) with FD-DpnI (Thermo Fisher Scientific Inc., 161 
Waltham, MA, USA) and purified either with QIAquick PCR purification kit or gel extraction kit 162 
(Qiagen, Hilden, Germany) (Supporting Information, Fig. S10, Fig. S13). DpnI was added to 163 
digest the methylated plasmids serving as starting material (template) in the PCRs, to reduce 164 
number of false positive clones in the following transformation. 165 
 166 
Typically, a 25 µl Golden Gate reaction (2.5 µl CutSmart buffer (10x), 1.25 µl T7 ligase, 1.25 µl 167 
BsaI-HF and 2.5 µl ATP (10 mM), New England Biolabs, Ipswich, MA, USA) was set up. The 168 
inserts were added in 10-fold molar excess to the backbone (ratio of 0.1 pmol insert to 0.01 pmol 169 
backbone). The reaction was performed in a thermo cycler (25x 37°C 2 min, 25°C 5 min; 37°C 170 
10 min; 80°C 10 min). For the Gibson Assembly reaction, 10 µl of the master mix (2x, New 171 
England Biolabs, Ipswich, MA, USA) were mixed with 0.01 pmol vector and 0.1 pmol insert. 172 
The reaction was incubated for 1 h at 50°C. For the replacement of the ybbR-tag with cysteine, 173 
the PCR linearized product was first digested with BsaI-HF together with FD-DpnI (1h, 37°C, 5 174 
Page 9 of 31
ACS Paragon Plus Environment
Biomacromolecules
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 10
min, 80°C). The reaction was supplied with 1 µl of dNTPs (10 mM, New England Biolabs, 175 
Ipswich, MA, USA), 1 µl of Klenow Fragment (10 U/µL, Thermo Fisher Scientific Inc., 176 
Waltham, MA, USA), and incubated (37°C, 15 min, and 75°C, 10 min). After a gel extraction, 177 
the corresponding band was excised and a blunt end reaction (6.5 µl PCR product, 1 µl ATP (10 178 
mM), 1 µl CutSmart buffer (10x), 0.5 µl PEG-6000, 1.0 µl T4 Polynucleotide Kinase, 1.0 µl T4 179 
Ligase) was set up (37°C 15 min, 22°C 45 min, 80°C 7 min). 180 
In case of the Golden Gate reaction, 10 µl and in case of the Gibson Assembly or the blunt end 181 
ligation 2 µl were used to transform DH5α cells (Life Technologies GmbH, Frankfurt, Germany; 182 
30 min on ice, 42°C 1 min, 1 h 37°C). The transformed culture was plated on appropriate 183 
antibiotic LB-Agar plates. A small number (<10) of clones were analyzed by colony PCR, or 184 
analytical restriction digestion (FD-EcoRI, Thermo Fisher Scientific Inc., Waltham, MA, USA) 185 
followed by sequencing (Supporting Information, Tab S1). 186 
 187 
Protein Expression. For ELP expression, chemically competent E. coli NiCo21(DE3) (New 188 
England Biolabs, Ipswich, MA, USA) were transformed with 50 ng plasmid DNA
37
. The cells 189 
were incubated in kanamycin containing, autoinducing ZYM-5052 media (supplemented with an 190 
amino acid mix 0.1 mg/ml) 24 h at 25°C
38–40
. After harvesting, ice cooled cells were lysed using 191 
sonication (Bandelin Sonoplus GM 70, Tip: Bandelin Sonoplus MS 73, Berlin, Germany; 40 % 192 
Power, 30 % Cycle 2x 10 min). The supernatant of the lysate (15000 g, 4°C, 1 h) was heated to 193 
60°C for 30 min to denature most of the E. coli host proteins. In a second step, the collapsed 194 
ELPs within this clouded solution were rehydrated by incubating under continuous mixing for 2 195 
h at 4°C. This allowed the resolubilization of the ELPs while the precipitated host proteins 196 
remained insoluble. A centrifugation step (15000 g, 4°C, 30 min) was used to separate the 197 
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soluble ELPs and remaining proteins from precipitated cell debris. The clear supernatant turned 198 
immediately cloudy after adding 1 M acetate buffer (final concentration 50 mM, pH 3.5), and 2 199 
M NaCl in crystalline form. The mixture was incubated for 30 min at 60°C. The collapsed ELPs 200 
were collected by centrifugation (3220 g, 40°C, 75 min). The obtained pellet was re-solubilized 201 
in 50 mM TRIS-HCl (pH 7.0) and incubated over night at 4°C. The remaining precipitated debris 202 
were removed by a final centrifugation step (3220 g, 4°C, 60 min). The supernatant was mixed 203 
again with acetate buffer and sodium chloride to collapse the ELPs. After the heated incubation 204 
and centrifugation step, the pellet was resolubilized in buffer (50 mM TRIS-HCl, pH 7.0)
14,41
. 205 
The purity of the ELP was confirmed by SDS-PAGE (Any kD
TM
 Mini-PROTEAN
®
 Stain-206 
Free
TM
 Gels, Bio-Rad Laboratories GmbH, Hercules, CA, USA), in order to detect any 207 
remaining contaminant host proteins. The ELPs were labeled with CoA-647 (New England 208 
Biolabs (Ipswich, MA, USA) and Sfp (37°C, 1 h, 5 mM MgSO4) to visualize them. After 209 
labeling, the ELPs were mixed with 6x Loading buffer and heated to 95°C for 10 min
42
. Usually 210 
a purity grade of >95% was obtained. Purity analysis was performed by overlaying the UV active 211 
Stain-Free
TM
 technology from Bio-Rad (labeling all tryptophan side groups of E. coli host 212 
proteins) and a fluorophore specific red channel for the CoA-647-ELP constructs (Supporting 213 
Information Fig. S11). MALDI-TOF analysis of ELP samples ELP30-50 was performed to 214 
increase confidence in the high purity of the samples (Supporting Information, Fig. S19). ELPs 215 
were stored at 4°C in 50 mM TRIS-HCl, pH 7.0. 216 
 217 
The final ELP concentration was photometrically determined at 205 nm (Ultrospec 3100 pro, 218 
Amersham Biosciences (Amersham, England) and TrayCell (Hellma GmbH & Co. KG, 219 
Müllheim, Germany))
43
.  220 
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 221 
For the expression of HIS6-TEV-GG-sfGFP, 50 ng plasmid DNA was used to transform E. coli 222 
NiCo21(DE3) cells. Kanamycin containing, autoinducing ZYM-5052 growth media was 223 
inoculated with an overnight culture
38
. After 24 h incubation at 25°C the cells were harvested, 224 
lysed and centrifuged as described above. The supernatant was applied on a HisTrap FF (GE 225 
Healthcare Europe GmbH, Freiburg, Germany). After washing five times with wash buffer (25 226 
mM TRIS-HCl pH 7.8, 300 mM NaCl, 20 mM Imidazole, Tween 20 0.25 % (v/v), 10 % (v/v) 227 
glycerol) the bound protein was eluted (25 mM TRIS-HCl pH 7.8, 300 mM NaCl, 300 mM 228 
Imidazole, Tween 20 0.25 % (v/v), 10 % (v/v) glycerol). 229 
 230 
HIS6-TEV-GG-sfGFP fusion protein (TEV cleavage site: ENLYFQG) was dialyzed immediately 231 
after elution with the TEV protease (4°C, 50 mM TRIS-HCl, pH 7.0) overnight. The cleaved 232 
product was separated from the uncleaved construct by applying the reaction mix on a HisTrap 233 
FF 5 ml column. The successfully cut fragment in the flow through was collected. The fraction 234 
was dialyzed against 50 mM TRIS-HCl, pH 7.0 and stored in 50 % (v/v) glycerol at -80°C. The 235 
purity of the elution and the cleaved fraction was analyzed via a SDS-PAGE analysis. The 236 
specific extinction coefficient of GFP at 485 nm was used to determine the concentration of GG-237 
sfGFP. 238 
 239 
Turbidity measurements. For the turbidity measurements, a photometer with a Peltier heating 240 
element was used (JASCO V-650, JASCO Germany GmbH, Gross-Umstadt, Germany). The 241 
turbidity was determined at 350 nm while the temperature was ramped at a rate of 2°C/min. 242 
Measurements were taken every 0.5°C between 20 and 80°C. ELPs were dialyzed against double 243 
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distilled water, mixed with a buffer stock solution (1 M TRIS-HCl, pH 7.0), sodium chloride 244 
stock solution (3 M or 5 M) and adjusted with water to the desired final concentration. 245 
 246 
For NaCl titration, 100 µM of the ELP constructs were tested in a range of 0 - 3 M sodium 247 
chloride. The 6x ELP construct was also probed in a concentration range of 25 µM - 200 µM 248 
with different NaCl concentrations.  249 
 250 
For pH titrations, stock solutions of 0.1 M phosphate-citrate buffer at different pH values were 251 
mixed with solutions of water solubilized ELPs. Hereby a final concentration of 0.05 M of the 252 
phosphate-citrate buffer was obtained.  253 
 254 
Data analysis of the transition temperature curves (for NaCl, pH, concentration dependency and 255 
PEG-ELP fusions) was performed by fitting the measured data points with a four-parameter 256 
logistic function to obtain the corresponding transition temperature.  257 
 258 
Sortase and Sfp-mediated protein ligation. For highest ligation efficiencies, enhanced Sortase 259 
(eSortase) was used in the reaction
44
. The reaction conditions for both Sfp and eSortase enzymes 260 
were chosen according their reported reaction maxima to achieve highest activities
28
. ELPs in 261 
excess were added to a solution containing 50 mM TRIS-HCl, pH 7.5, 15 µM ELP, 0.5 µM GG-262 
sfGFP, 0.2 µM eSortase, 1 µM Sfp, 5 mM CaCl2, 5 mM MgCl2, 5 µM CoA-647. The ligation 263 
reaction was incubated for 2 h at 37°C. 264 
 265 
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Cysteine-Maleimide bioconjugation reaction. Cysteine-containing ELPs were reduced with 5 266 
mM tris(2-carboxyethyl)phosphine (TCEP, (Thermo Fisher Scientific Inc., Waltham, MA, 267 
USA)). After the removal of TCEP with Zeba
TM
 Spin Desalting Columns 7K (Thermo Fisher 268 
Scientific Inc., Waltham, MA, USA) cysteine-ELPs were mixed with Alexa647-C2-Maleimide 269 
(Thermo Fisher Scientific Inc., Waltham, MA, USA) and incubated for 1 h at 37°C (100 mM 270 
TRIS-HCl, pH 7.0) (Supporting Information, Fig. S20). 271 
PEG (MW: 20,000 Da, α-Methoxy-ω-maleimide, Rapp Polymere GmbH, Tübingen, Germany) 272 
was used in different molar ratios in the bioconjugation reaction with cysteine-ELP60 or ELP60. 273 
75 µM of the reduced ELPs were mixed with TRIS-HCl (pH 7.0, 100 mM), PEG, and incubated 274 
for 1 h at room temperature. After that they were mixed with 5 M NaCl and to a final 275 
concentration of 3 M NaCl and their cloud point was determined as described above. 276 
 277 
RESULTS AND DISCUSSION  278 
Our sequence independent Golden Gate-based method provides an easy way to create defined 279 
repetitive DNA sequences
26
. We designed and produced gene cassettes encoding repetitive 280 
proteins several hundreds of amino acids in length. Fig. 1 outlines the principle of primer design 281 
and the following logical and stepwise workflow. The sequence of the starting synthetic gene 282 
was designed in such a way that the codon usage within the first and last 15 nucleotides was 283 
unique within the otherwise repetitive 150 bp sequence. This was necessary to ensure specific 284 
annealing of primers at the 5’ and 3’ end. Desired modifications were introduced by overhangs 285 
of the primers at their 5’ end (i.e. BsaI recognition site) or at their 3’ region (codon shuffling of 286 
nucleotides). It was then possible to create 150 bp ELP genes with different flanking regions 287 
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from the same template (Primers 1-3; Fig. 1 A) using PCR primers that annealed at the 5’ and 3’ 288 
ends of the synthetic gene.  289 
 290 
In the first amplification and linearization reaction of the plasmid, primers annealed at the 291 
desired ELP gene insertion site, i.e. at the opening location on the plasmid during the first PCR. 292 
In our case this was downstream of the T7 promoter and upstream of the T7 terminator (see 293 
Supporting Information Fig. S8 and S9). However, due to the freedom of primer design and 294 
plasmid choice, the insertion site can in principle be anywhere in the plasmid. The primers 295 
linearized the plasmid and introduced tags at the 5’ (ybbR-tag) and 3’ (Sortase c-tag) prime ends, 296 
as well as BsaI recognition sites (Primers 5, 6; Vector A; Fig. 1 A). In our case, a modified 297 
pET28a vector, already containing a ybbR-site downstream of the T7 promotor immediately 298 
following the start codon AUG, served as template. Hence, only the Sortase c-tag was newly 299 
introduced (see Supporting Information for primers for the standard pET28a vector). The 300 
continuing general ELP expansion principle relies on having three different PCR amplified ELP 301 
fragments (I, II, III) with different codon usages at their 5’ and 3’ end, within the BsaI-restriction 302 
site (Supporting Information Fig. S1-S6). This design made logical and block-wise gene 303 
assembly possible. The selected primers introduced a shuffled 3’ end which matched the 5’ end 304 
of the subsequent fragment. In the first ELP assembly round, the 5’ end of fragment I matched 305 
the ybbR-tag of the linearized backbone. The 3’ end of fragment III had compatible sticky ends 306 
with the Sortase c-tag of the linearized plasmid (Fig. 1 B, 1st round). After successful annealing 307 
of sticky ends, the T7 ligase covalently linked the three ELP fragments seamlessly into the 308 
plasmid without any undesirable cloning scars in between. 309 
 310 
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The forward primer (Fig. 1 A, 2
nd
: Primer 7) for the following plasmid linearization rounds 311 
annealed at a different site within the ELP-containing plasmid, compared to the initial 312 
linearization round (Fig. 1 A, 1
st
: Primer 5). It annealed at the ybbR-tag and the 5’ end of the 313 
ELP gene. Right in between the two coding regions, a non-annealing loop encoding a BsaI 314 
recognition site was introduced (Fig. 1 A 2
nd
, and Fig. 1 B 2
nd
 round) with the primer. The 315 
annealing at the ybbR-tag was necessary to ensure high temperature-dependent primer annealing 316 
specificity at the very 5’ end of the ELP gene, otherwise the primer would anneal at every 317 
fragment I throughout the whole assembled ELP gene cassette. High annealing temperatures 318 
minimize undesired PCR side products, i.e. only partly ELP-containing, linearized vectors. The 319 
reverse primer was the same for all plasmid linearization reactions (Fig. 1 A; Vector B). After 320 
the restriction digestion reaction, the linear plasmid now had a Sortase c-tag sticky end at the 3’ 321 
end and an ELP fragment I sticky end at the 5’ end.  322 
 323 
Now only the last ELP fragment (Fig. 1 A, Insert IV) had to be amplified with a different reverse 324 
primer (Fig. 1 A, Primer 4) to yield a PCR product with a compatible 3’ end to the already 325 
existing ELP cassette. The growing ELP insert in the plasmid always started with fragment I. 326 
This made the reuse of the amplified insert sequences (I, II, IV) for every following expansion 327 
cloning round possible (Fig .1 B, >3
rd
 rounds).  328 
 329 
This method not only allows a logical assembly of repetitive gene patterns, but also makes the 330 
modification of flanking regions or mutation of the first base pairs at 5’ end 3’ end possible. For 331 
example, we introduced two glutamates in each of the fragments at their 5’ and 3’ ends by 332 
changing the codon from the ‘X’ guest residue at the 5’ and 3’ end of the VPGXG motif to a 333 
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glutamate (VPGEG). The primers did not align completely with the template and introduced the 334 
glutamate mutation during PCR amplification. The chemically synthesized sequence also had 335 
some minor mistakes at the 3’ end, which were corrected with primers within the initial PCR. 336 
The final ELP substructure of all ELPs used in this study consisted of 10 pentapeptide repeats 337 
(VPGXG10, X being [EV4A2G2E]). For the rest of the manuscript this motif is referred as ELPn 338 
with n being the number of pentapeptide repeats of this motif (see Supporting Information, DNA 339 
Sequence 2, Protein Sequence 2 and DNA Sequence 7, Protein Sequence 3). 340 
 341 
We ligated three 150 bp fragments with a linearized vector of choice in one step. It was possible 342 
to modify the 5’ and 3’ ends of the fragments with overhang primers prior to ligation, in our case 343 
with an N-terminal ybbR and a C-terminal Sortase tag (Fig. 1 B). Overall seven different ELP 344 
constructs were used in this study for biophysical characterization of the peptide sequence, while 345 
ten were successfully cloned. The largest ELP gene contained 120 pentapeptide repeats. All ELP 346 
constructs were built with the four different ELP PCR products from the same batch. PCR gels 347 
from the fragments and an overview of cloning efficiencies can be found in the supporting 348 
information (Fig. S9 and Tab. S1). Typical yields after the purification were 56 – 138 mg 349 
Protein/l culture, while the ELP10 repeat had the lowest yield (2 mg Protein/l culture). 350 
 351 
Tab. 2 shows biophysical characteristics of the ELPs characterized in this study. Each ELP was 352 
produced with a ybbR-tag at the N-terminus and a Sortase c-tag at the C-terminus. In the bottom 353 
right corner of the schematic (Fig. 1), FD-EcoRI digested plasmids are shown on an agarose gel. 354 
The gel analysis shows the successful construction of plasmids containing 10 to 120 355 
pentapeptide repeats. 356 
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Table 2. Biophysical properties of the characterized ELP constructs. 357 
ELP 
repeats 
(5)x 
ε205 
[1/M 
cm]
43
 
Molecular 
weight 
[Da]
45
 
Glutamate 
residues in 
ELP repeat 
Isoelectric 
point
45
 
Amino 
acids in 
ELP 
repeats 
(total) 
Total 
Length 
[nm]
46
 
10 196690 5893.7 2 3.91 50 (68) 24.82 
20 335690 9908.2 4 3.77 100 (118) 43.07 
30 474690 13922.8 6 3.67 150 (168) 61.32 
40 613690 17937.3 8 3.59 200 (218) 79.57 
50 752690 21951.9 10 3.53 250 (268) 97.82 
60 891960 25966.4 12 3.47 300 (318) 116.07 
Cys-60 855980 24894.2 12 3.20 300 (308) 112.42 
 358 
Following successful cloning, expression and purification, we tested the functionality of the 359 
attached terminal tags. Fig. 2 A shows the scheme for post-translational protein ligation 360 
reactions. The ELPs of varying lengths contain an N-terminal ybbR-tag and a C-terminal Sortase 361 
recognition sequence (i.e., LPETGG). Subpanel 2 B to 2 C show an SDS-PAGE image of the 362 
same gel with different excitation and emission filters. Using a reaction catalyzed by Sfp, it was 363 
possible to fuse a fluorescently labeled CoA-647 to the ELP (N-terminal ybbR-tag). Results of 364 
the specific excitation for the CoA-647 dye are shown in 2 B. Brightest are the CoA-647-ELP 365 
fusions proteins, but also the CoA-647-ELP-sfGFP fusion proteins are visible above the bright 366 
monomer band. Fully denatured proteins appear slightly higher in the gel due to their different 367 
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running behavior. The Sortase-tag was simultaneously utilized for fusion of different proteins to 368 
the ELP sequences (C-terminal LPETGG). A GG-sfGFP was fused to the ELPs, which was 369 
excited with blue LED light and detected within the green emission of sfGFP (Fig. 2 C). Non-370 
ligated and non-denaturated GFP appears at the top of the gel, since it does not run according its 371 
molecular weight in its native (i.e., correctly folded) state (see Supporting Information, Fig. 372 
S12). No GFP fluorescence is visible in the heated samples due to complete denaturation of the 373 
GFP chromophore. Panel 2 D shows an overlay of B and C, visualizing the successful post-374 
translational ligation of GG-sfGFP and CoA-647 to the different ELP peptides within a one-pot 375 
reaction. The ligation efficiency of the Sortase never goes to 100 % completion. Due to the 376 
Sortase reaction mechanism, a dynamic equilibrium is eventually reached and complete fusion of 377 
GG-sfGFP to ELP is therefore not to be expected
47
.  378 
 379 
After confirming the biochemical accessibility and functionality of the terminal ybbR- and 380 
Sortase-tags, we characterized the phase behavior of the modified ELPs. Fig. 3 presents an 381 
overview of the lower critical solution temperatures (LCSTs) of the characterized ELPs under 382 
various conditions. First the temperature dependence of the ELP10-60 constructs were probed 383 
against different sodium chloride concentrations, at neutral pH (50 mM TRIS-HCl, pH 7.0) (Fig. 384 
3 A). The 10 pentapeptide repeat ELP did not collapse below 80°C, which is in agreement with 385 
the remainder of the data set if one looks at the increasing transition temperature with decreasing 386 
size of the construct. The 20 pentapeptide ELP repeat, for example, only collapsed with 3 M of 387 
sodium chloride at 60°C. Fig. 3 B clarifies the correlation between salt concentration, molecular 388 
mass and transition temperatures. Only the longest ELP construct collapsed across all given 389 
sodium chloride concentrations in the temperature range from 20 to 80°C. Salt-induced cloud 390 
point shifts are a well known characteristic of ELPs
15,24,48
. 391 
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 392 
The incorporation of two glutamates per ten pentapeptides resulted in pH-dependent transitions. 393 
ELPs with glutamates were expected to show pH-responsiveness. Above their pKa the ELPs have 394 
a relatively high transition temperature, since the glutamates are deprotonated and ionized and 395 
therefore electrostatically repel each other. Below or close to their corresponding pKa, the 396 
transition temperature significantly decreases due to protonation and neutralization of the 397 
negative charge (Fig. 3 C). The decreasing influence of salt at lower pH is similar to that 398 
demonstrated by MacKay et al.
49
. Fig. 3 D illustrates the dependence of transition temperature 399 
on the ELP concentration. At concentrations above 100 µM, the 60 pentapeptide ELP (150, 200 400 
µM) already collapsed at room temperature, hence it was not possible to determine an exact 401 
transition point. The ligated product between the 60 pentapeptide ELP repeat and the sfGFP did 402 
not show any transition compared to the pure 60 pentapeptide ELP (data not shown). This 403 
concentration dependence is also a well-known characteristic of ELPs
10
. 404 
 405 
This PCR based method can also be employed to change the flanking sequences of the ELP very 406 
quickly. Fig. 4 A shows the underlining principle of the cloning procedure used to install 407 
cysteine as an end residue with no cloning scar. Due to the repetitive structure of the ELP gene it 408 
was necessary to design primers which anneal at the site of replacement. A BsaI recognition loop 409 
between ELP annealing and deletion annealing site was necessary to remove the deletion site 410 
again afterwards. BsaI digestion left incompatible 5’ and 3’ sticky ends, therefore a Klenow 411 
Fragment was employed to fill the ends. A standard blunt end ligation circularized the linear 412 
plasmid (Fig. 4A and Supporting Information: Fig. S13-S18). This procedure provided an N-413 
terminal cysteine that could be used for bioconjugations to various (macro)molecules (see 414 
Supporting Information, DNA Sequence 9, Protein Sequence 5). The cysteine in the ELP is able 415 
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to form disulfide bonds with different cysteine containing proteins, but also is able to be clicked 416 
to other reactive groups like maleimide (i.e. a maleimide-PEG (Fig. 4 B)). The cloud point 417 
determination of Fig. 4 C shows the influence of PEG conjugation on the ELP cloud point, 418 
confirming a shift towards higher temperatures (Fig. 4 C, CYS-ELP60) due to conjugation of the 419 
hydrophilic synthetic polymer. However, the same PEG added to a solution of the same ELP that 420 
lacked the cysteine functionality did not significantly influence the cloud point (Fig. 4 C, ELP60). 421 
 422 
CONCLUSION  423 
The presented approach shows an alternative way to create fast and convenient functional ELPs 424 
with sequence lengths up to 600 amino acids, or hundreds of nm in stretched contour length. It 425 
allows a straightforward fusion of gene sequences encoding the ELP repeats without any prior 426 
vector modifications. We used this approach to demonstrate facile incorporation of functional 427 
peptide tags as end groups into ELPs. We demonstrate how this approach was useful for 428 
developing end-labeled ELPs through enzyme-mediated site-specific ligation to organic dyes and 429 
fluorescent proteins, and show how terminal cysteine incorporation expands the versatile toolbox 430 
of bioconjugation opportunities. Since we used a PCR and primer-based approach, our method is 431 
essentially sequence independent and does not leave cloning scars. In the future we anticipate 432 
that such a tool for straightforward end-group modification of ELPs will prove useful for 433 
developing custom engineered macromolecular systems.  434 
 435 
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Additional information including sequence data (DNA and Protein sequences), extended cloning 438 
procedures and gel pictures of PCR products and protein purification steps.  439 
This material is available free of charge via the Internet at http://pubs.acs.org. 440 
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FIGURE CAPTIONS 546 
Figure 1. Cloning schematic 547 
(A) The schematic describes the process of sequence independent PCR amplification of unique 548 
inserts (I, II, III) from the same template. The amplification of the first backbone (plasmid A) 549 
enables subcloning of the first three inserts, which leads to plasmid B. Plasmid B is linearized at 550 
the N-terminal ybbR-tag, as are all the following backbones. The new ELP amplicons can always 551 
be inserted upstream of the old ELP repeats. (B) Repetitive rounds of cloning add subsequently 552 
more ELP inserts until the desired length is achieved. 553 
Figure 2. Post-translational ligation of the ELP peptide 554 
(A) Schematic of the ELP constructs containing a N-terminal ybbR-tag and a C-terminal Sortase-555 
tag. A post-translational one-pot reaction was used to fuse a CoA-647 fluorescent dye to the N-556 
Termini via an Sfp-catalyzed reaction. In parallel, the eSortase fuses a GG-sfGFP towards the C-557 
terminal LPETGG. (B) An image of a SDS gel obtained following dual labeling of ELPs under 558 
different reaction conditions and ELP lengths. The image shows only the red CoA-647 dye (ex: 559 
530/28, em: 695/55 nm). (C) Fluorescent image of the same gel as in B, but this time with blue 560 
excitation (ex: 470/530, em: 530/28 nm), hence only the native GFP specific bands are visible. 561 
(D) Overlay of B and C plus additional UV illumination which excites tryptophan side group 562 
converted fluorophores enabled by the Bio-Rad Stain-Free
TM
 technology. 563 
Figure 3. Cloud point characterization of the 10 – 60 pentapeptide ELP repeats  564 
(A) shows the characteristic decrease in the transition temperature of the ELPs with increasing 565 
sodium chloride concentration and ELP length. (B) illustrates the relation between increasing 566 
transition temperature and decreasing molecular weight. (C) shows the correlation between pH, 567 
NaCl and transition temperature. (D) shows the concentration dependency of the transition 568 
temperature for the 60 pentapeptide ELP repeat. Data points for the plots were obtained from 569 
triplicates. Error bars represent the standard deviation of the average transition point. 570 
Figure 4. Cloning schematic and bioconjugation of cysteine-ELPs with a maleimide-dye and 571 
PEG-maleimide.   572 
(A) Illustration of the cloning schematic for changing the ELP flanking regions (i.e. replacement 573 
of the ybbR-sequence with a cysteine). The ybbR-sequence was deleted via a PCR reaction, and 574 
a cysteine was introduced (see Primers 10 and 11 in Table 1). The flanking restriction sites were 575 
digested with BsaI-HF and the remaining sticky ends were filled in with Klenow Fragment. 576 
Finally, the linear product was circularized with T4 ligase. (B) Procedure of the bioconjugation 577 
reaction. Cysteine-ELPs were reduced with TCEP and conjugated to a maleimide dye or a PEG-578 
maleimide polymer. A gel image on the right shows the successful conjugation reaction between 579 
the dye and the ELP. (C) Bioconjugation of a 20 kDa PEG-maleimide to CYS-ELP60 shifted the 580 
cloud point up by ~4°C (left panel). The cloud point of ELP60 lacking cysteine (middle panel) 581 
was not influenced by the addition of maleimide PEG. The right panel shows the cloud point 582 
shift (∆T) due to addition of different concentrations of PEG-maleimide. Data points for the plot 583 
were obtained from triplicates. Error bars account for Gaussian error propagation due to 584 
calculation of the difference of the average transition point from three samples.  585 
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